JPMorgan Chase & Co. Issues Positive Forecast for Johnson Controls International (NYSE:JCI) Stock Price

Johnson Controls International (NYSE:JCI) had its target price increased by JPMorgan Chase & Co. from $105.00 to $125.00 in a research report report published on Wednesday morning,Benzinga reports. The firm currently has an overweight rating on the stock.

A number of other equities analysts have also recently weighed in on JCI. Jefferies Financial Group reaffirmed a “hold” rating and issued a $120.00 price target on shares of Johnson Controls International in a report on Thursday, July 24th. Citigroup upped their price target on Johnson Controls International from $112.00 to $119.00 and gave the stock a “neutral” rating in a report on Thursday, October 9th. Oppenheimer cut Johnson Controls International from an “outperform” rating to a “market perform” rating in a report on Friday, June 20th. The Goldman Sachs Group upped their price target on Johnson Controls International from $119.00 to $124.00 and gave the stock a “buy” rating in a report on Monday, September 15th. Finally, Barclays upped their price target on Johnson Controls International from $100.00 to $101.00 and gave the stock an “equal weight” rating in a report on Wednesday, July 30th. Ten investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $110.89.

Johnson Controls International Stock Up 2.7%

Shares of JCI opened at $110.73 on Wednesday. Johnson Controls International has a 52 week low of $68.03 and a 52 week high of $112.63. The company has a quick ratio of 0.81, a current ratio of 0.96 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $72.46 billion, a price-to-earnings ratio of 32.86, a PEG ratio of 1.62 and a beta of 1.33. The stock’s 50-day moving average price is $107.14 and its 200-day moving average price is $99.70.

Johnson Controls International (NYSE:JCI) last issued its earnings results on Tuesday, July 29th. The company reported $1.05 EPS for the quarter, topping analysts’ consensus estimates of $0.99 by $0.06. Johnson Controls International had a return on equity of 14.71% and a net margin of 9.53%.The firm had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $5.99 billion. Johnson Controls International has set its FY 2025 guidance at 3.650-3.680 EPS. Q4 2025 guidance at 1.140-1.170 EPS. On average, sell-side analysts predict that Johnson Controls International will post 3.64 EPS for the current year.

Johnson Controls International Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 17th. Investors of record on Monday, September 22nd will be issued a $0.40 dividend. This is a boost from Johnson Controls International’s previous quarterly dividend of $0.37. This represents a $1.60 annualized dividend and a dividend yield of 1.4%. The ex-dividend date of this dividend is Monday, September 22nd. Johnson Controls International’s payout ratio is 47.48%.

Insider Activity at Johnson Controls International

In other Johnson Controls International news, VP Nathan D. Manning sold 1,422 shares of the firm’s stock in a transaction on Tuesday, September 2nd. The stock was sold at an average price of $105.06, for a total transaction of $149,395.32. Following the completion of the sale, the vice president owned 139,459 shares of the company’s stock, valued at $14,651,562.54. This trade represents a 1.01% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Daniel C. Mcconeghy sold 5,917 shares of the firm’s stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $105.73, for a total value of $625,604.41. Following the sale, the vice president directly owned 25,005 shares of the company’s stock, valued at approximately $2,643,778.65. This trade represents a 19.14% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 8,761 shares of company stock valued at $922,447. Insiders own 0.54% of the company’s stock.

Institutional Investors Weigh In On Johnson Controls International

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Truvestments Capital LLC increased its stake in Johnson Controls International by 425.0% during the first quarter. Truvestments Capital LLC now owns 315 shares of the company’s stock worth $25,000 after acquiring an additional 255 shares during the last quarter. Accent Capital Management LLC acquired a new stake in Johnson Controls International during the first quarter worth $26,000. Cornerstone Planning Group LLC increased its stake in Johnson Controls International by 74.5% during the first quarter. Cornerstone Planning Group LLC now owns 363 shares of the company’s stock worth $28,000 after acquiring an additional 155 shares during the last quarter. Caitong International Asset Management Co. Ltd acquired a new stake in Johnson Controls International during the second quarter worth $28,000. Finally, Activest Wealth Management increased its stake in Johnson Controls International by 56.4% during the first quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $30,000 after acquiring an additional 133 shares during the last quarter. Institutional investors and hedge funds own 90.05% of the company’s stock.

Johnson Controls International Company Profile

Johnson Controls International plc, together with its subsidiaries, engages in engineering, manufacturing, commissioning, and retrofitting building products and systems in the United States, Europe, the Asia Pacific, and internationally. It operates in four segments: Building Solutions North America, Building Solutions EMEA/LA, Building Solutions Asia Pacific, and Global Products.